FOXQ1 Antikörper (full length)

Produktnummer ABIN7878252

Der Maus Monoklonal anti-FOXQ1 Antikörper wird verwendet zum Nachweis von FOXQ1 in Proben von Human. Er wurde validiert für ELISA, WB und FACS.

Kurzübersicht für FOXQ1 Antikörper (full length) (ABIN7878252)

Target: FOXQ1 (Forkhead Box Q1 (FOXQ1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser FOXQ1 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Flow Cytometry (FACS)

Güteklasse: Carrier-free

Klon: PCRP-FOXQ1-2D2

Produktdetails anti-FOXQ1 Antikörper

Bindungsspezifität: full length

Verwendungszweck: FOXQ1 Antibody (azide and preservative free)

Aufreinigung: Protein A/G affinity

Immunogen: Recombinant full-length human FOXQ1 protein was used as the immunogen for the FOXQ1 antibody.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the FOXQ1 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Konservierungsmittel: Azide free

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the FOXQ1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu FOXQ1

Target: FOXQ1 (Forkhead Box Q1 (FOXQ1))

Andere Bezeichnung: FOXQ1

Hintergrund: DNA replication is initiated by the binding of initiation factors to the origin of replication. Nucleosomes inhibit access to the replication machinery at these origin sequences. Nucleosome remodeling factors increase the accessibility of nucleosomal DNA to transcriptional regulators. CHRAC15 and CHRAC17 are subunits of the nucleosomal remodeling factor CHRAC (chromatin accessibility complex), which increases the accessibility of nucleosomal DNA in an ATP-dependent manner. Unlike other known chromatin remodeling factors, CHRAC also functions during chromatin assembly by using ATP to convert irregular chromatin into a regular array of nucleosomes with even spacing. This conversion process occurs when CHRAC organizes randomly deposited histones into a regularly spaced array. In the presence of CHRAC, the nucleosomal ATPase ISWI catalyzes several ATP-dependent transitions of chromatin structure.

UniProt: Q9C009

Pathways: Positive Regulation of Endopeptidase Activity